1. Home
  2. About Us
  3. News

News

News

$5 Million Gift to Case CCC Follows New Director to Cleveland

October 6, 2023

Vaccine for Triple Negative Breast Cancer Looks Promising in Trial

October 6, 2023

Three Case CCC Members to Play Pivotal Roles in Interdisciplinary Collaborative

September 15, 2023

Saltzman Named ASCO Fellow

September 8, 2023

Cao and Team Challenge Current Assumptions about Slowing Cancer Growth by Stopping Overexpression of LSD1 Proteins

September 8, 2023

CAAPP Featured on Sound of Ideas

September 8, 2023

Undergrad Summer Education Programs Score with Another Successful Summer

August 22, 2023

Healthy Futures Research Project Kicks Off

August 22, 2023

SEO/YES Celebrates 20 Successful Years with Largest Group Ever

August 11, 2023

Cullen and Montero Published in JNCCN

July 13, 2023

Clark Distelhorst Passes Away

July 10, 2023

Sossey-Alaoui Receives $2.3M from NIH to Study Breast Cancer and Health Disparities in African-American Women

July 7, 2023

Case CCC Research Teams Receive Awards

July 5, 2023

Emerging Researchers Program Kicks Off Second Year

July 3, 2023

A new study published in NEJM Evidence with University Hospitals Seidman Cancer Center researchers and ArteraAI validates the first-ever predictive AI biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer

June 30, 2023